Investor Notice: Robbins LLP Informs Investors of the Bath & Body Works, Inc. Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Bath & Body Works, Inc. (NYSE: BBWI) securities between June 4, 2024 and November 19, 2025. Bath & Body Works is a specialty retailer of home fragrance and body care products.

Robbins LLP is Investigating Allegations that Bath & Body Works, Inc. (BBWI) Misled Investors Regarding its Business Strategy

Share

For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.

The Allegations: Robbins LLP is Investigating Allegations that Bath & Body Works, Inc. (BBWI) Misled Investors Regarding its Business Strategy

According to the complaint, defendants failed to disclose to investors: (1) the Company's strategy of pursuing "adjacencies, collaborations and promotions" was not growing the customer base and/or delivering the level of growth in net sales touted; (2) as the Company's strategy of "adjacencies, collaborations and promotions" faltered, the Company relied on brand collaborations "to carry quarters" and obfuscate otherwise weak underlying financial results; and (3) as a result, the Company was unlikely to meet its own previously issued financial guidance.

Plaintiff alleges that on November 20, 2025, Bath & Body Works released disappointing third quarter 2025 financial results, including that revenue declined 1% year over year, missed guidance of 1-3% growth for the quarter, and a decline in net income by 26% to $77 million. The Company slashed full-year guidance for net sales and cut expected earnings per diluted share from $3.28 to $3.53 to "at least $2.83."

In an investor presentation published the same day, the Company announced a new business strategy and admitted its strategy of "adjacencies, collaborations and promotions" had "not grown our total customer base." The Company also offered a "diagnosis" of its underperformance, including that the focus on adjacencies had "reduced focus on investing in our core categories;" that collaborations "have been used to carry quarters;" and that the Company had become "overly reliant on deeper and more frequent promotions to drive growth. " The Company announced would exit certain adjacencies and instead focus on core categories.

On this news, Bath & Body Works' stock price fell $5.22, or 24.8%, to close at $15.82 per share on November 20, 2025

What Now: You may be eligible to participate in the class action against Bath & Body Works, Inc. Shareholders who wish to serve as lead plaintiff for the class should contact Robbins LLP. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002.

To be notified if a class action against Bath & Body Works, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.